U.S. Markets closed

ImmunoGen, Inc. (IMGN)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
7.00+0.46 (+7.03%)
At close: 4:00PM EDT

7.05 0.05 (0.71%)
After hours: 7:34PM EDT

People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue60,00285,54159,896
Cost of Revenue---
Gross Profit60,00285,54159,896
Operating Expenses
Research Development148,077111,768106,958
Selling General and Administrative36,91628,22824,469
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-124,991-54,455-71,531
Income from Continuing Operations
Total Other Income/Expenses Net-19,826-6,284167
Earnings Before Interest and Taxes-144,817-60,739-71,364
Interest Expense---
Income Before Tax-144,817-60,739-71,364
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-144,817-60,739-71,364
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-144,817-60,739-71,364
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-144,817-60,739-71,364